Pathophysiology of infective endocarditis

Current Infectious Disease Reports

Volumn 15, Issue 4, 2013, Pages 342-346

  Keynan, Yoav ^a   Rubinstein, Ethan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adhesins; Bacterial adhesion to endocardial cells; Endocarditis; Heart lesions predisposing to endocarditis; Intracardiac hemodynamics predisposing to endocarditis

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; BLOOD FLOW; ENDOTHELIUM; FIBRIN CLOT; HEART VALVE; HUMAN; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; STAPHYLOCOCCAL BACTEREMIA; THROMBOCYTE AGGREGATION;

EID: 84880767034     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0346-0     Document Type: Article

References (30)

1. Chang FY, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82(5):322-32.
2. Fowler Jr VG, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163(17):2066-72.
3. Garrison PK, Freedman LR. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med. 1970;42(6):394-410.
4. Durack DT. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol. 1975;115(2):81-9.
5. O'Brien L, et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol. 2002;44(4):1033-44.
6. McNicol A, Israels SJ. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol. 2010;88(5):510-24.
7. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4(6):445-57.
8. Freedman LR, Valone Jr J. Experimental infective endocarditis. Prog Cardiovasc Dis. 1979;22(3):169-80.
9. Gould K, et al. Adherence of bacteria to heart valves in vitro. J Clin Invest. 1975;56(6):1364-70.
10. Didierlaurent A, Goulding J, Hussell T. The impact of successive infections on the lung microenvironment. Immunology. 2007;122(4):457-65.
11. Scheld WM, Valone JA, Sande MA. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest. 1978;61(5):1394-404.
12. Edwards AM, et al. Staphylococcus aureus extracellular adherence protein triggers TNFalpha release, promoting attachment to endothelial cells via protein A. PLoS One. 2012;7(8):e43046.
13. Bayer AS, et al. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun. 1997;65(11):4652-60.
14. •• Schubert S, et al. Staphylococcus aureus alpha-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel). 2011;3(2):120-33. An important study illustrating the effect of staphylococcal alpha toxin on immediate and prolonged platelet activation, which could be decreased by targeting mTOR.
15. •• Yamaguchi T, Soutome S, Oho T. Identification and characterization of a fibronectin-binding protein from Granulicatella adiacens. Mol Oral Microbiol. 2011;26(6):353-64. Identification of a surface protein, designated Cha, which binds to fibronectin and is involved in adherence to fibronectin. May provide potential therapeutic target.
16. Yeaman MR, et al. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis. 1992;166(1):65-73.
17. Josefsson E, et al. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology. 1998;144(12):3387-95.
18. Kuypers JM, Proctor RA. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun. 1989;57(8):2306-12.
19. Moreillon P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738-43.
20. • Veloso TR, et al. Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun. 2013;81(3):697-703. Important study hgihlighting the role of bacterial adhesins in initiation and subsequent prpogation of endocariditis lesion.
21. Yeh CY, Chen JY, Chia JS. Glucosyltransferases of viridans group streptococci modulate interleukin-6 and adhesion molecule expression in endothelial cells and augment monocytic cell adherence. Infect Immun. 2006;74(2):1273-83.
22. McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82(4):681-8.
23. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368(15):1425-33.
24. Weinberger I, et al. Native valve infective endocarditis in the 1970s versus the 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol. 1990;13(2):94-8.
25. Lepeschkin E. On the relation between the site of valvular involvement in endocarditis and the blood pressure resting on the valve. Am J Med Sci. 1952;224(3):318-9.
26. Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J. 1995;16(Suppl B):2-6.
27. Bansal RC. Infective endocarditis. Med Clin North Am. 1995;79(5):1205-40.
28. Millaire A, et al. Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery. Clin Infect Dis. 1996;22(1):192-3.
29. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17(3):313-20. quiz 321-2.
30. Rodbard S. Blood velocity and endocarditis. Circulation. 1963;27:18-28.